These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38910661)

  • 61. MiR-92b as a marker for TPF induced chemotherapy response prediction and prognosis evaluation in with advanced oral squamous cell carcinoma patients.
    Wen J; Xu H; Liu R; Chen Q; Dai Y; Xu Y
    Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):24-31. PubMed ID: 32538743
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Implications for clinical staging of metastatic cutaneous squamous carcinoma of the head and neck based on a multicenter study of treatment outcomes.
    Andruchow JL; Veness MJ; Morgan GJ; Gao K; Clifford A; Shannon KF; Poulsen M; Kenny L; Palme CE; Gullane P; Morris C; Mendenhall WM; Patel KN; Shah JP; O'Brien CJ
    Cancer; 2006 Mar; 106(5):1078-83. PubMed ID: 16444748
    [TBL] [Abstract][Full Text] [Related]  

  • 63. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
    Lu M; Wang C; Chen W; Mao C; Wang J
    DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Overview of the 8th Edition TNM Classification for Head and Neck Cancer.
    Huang SH; O'Sullivan B
    Curr Treat Options Oncol; 2017 Jul; 18(7):40. PubMed ID: 28555375
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland.
    O'Brien CJ; McNeil EB; McMahon JD; Pathak I; Lauer CS; Jackson MA
    Head Neck; 2002 May; 24(5):417-22. PubMed ID: 12001070
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparison of CT, MRI, and F-18 FDG PET/CT for initial N-staging of oral squamous cell carcinoma: a cost-effectiveness analysis.
    Burian E; Palla B; Callahan N; Pyka T; Wolff C; von Schacky CE; Schmid A; Froelich MF; Rübenthaler J; Makowski MR; Gassert FG
    Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3870-3877. PubMed ID: 35606526
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Key proteins of invadopodia are overexpressed in oral squamous cell carcinoma suggesting an important role of MT1-MMP in the tumoral progression.
    Mitre GP; Balbinot KM; Ribeiro ALR; da Silva Kataoka MS; de Melo Alves Júnior S; de Jesus Viana Pinheiro J
    Diagn Pathol; 2021 Apr; 16(1):33. PubMed ID: 33879222
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Expression of beta adrenergic receptor in oral squamous cell carcinoma and its significance to the prognosis.
    Dong H; Liao XX; Mai HM; Zhou N; Wang DY; Peng JB; Yang LH
    Int J Clin Exp Pathol; 2017; 10(10):10431-10440. PubMed ID: 31966380
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Expression of pro-inflammatory protein, iNOS, VEGF and COX-2 in oral squamous cell carcinoma (OSCC), relationship with angiogenesis and their clinico-pathological correlation.
    Sappayatosok K; Maneerat Y; Swasdison S; Viriyavejakul P; Dhanuthai K; Zwang J; Chaisri U
    Med Oral Patol Oral Cir Bucal; 2009 Jul; 14(7):E319-24. PubMed ID: 19300368
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Improving accuracy in nodal staging of oral cancer: Proposal of a new system.
    Subramaniam N; Heller G; Clark JR; Gupta R; Goldstein D; de Almeida JR; Hosni A; Balasubramanian D; Thankappan K; Iyer S; Batstone M; Iyer NG; Smee RI; Chandrasekhar NH; Pillai V; Shetty V; Rangappa V; Veness M; Low TH
    Surg Oncol; 2024 Feb; 52():102033. PubMed ID: 38211447
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Incorporating the epidermal growth factor receptor expression and histopathological parameters in a mathematical model to predict the prognosis of oral squamous cell carcinoma: a prospective observational cohort study.
    Akheel M; Senthilmurugan M; Jain A; Chahwala Q; Sherlin HJ; Wadhwania A
    J Maxillofac Oral Surg; 2022 Dec; 21(4):1065-1073. PubMed ID: 36896074
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Analysis of selected risk factors for nodal metastases in head and neck cutaneous squamous cell carcinoma.
    Szewczyk M; Pazdrowski J; Golusiński P; Dańczak-Pazdrowska A; Marszałek S; Golusiński W
    Eur Arch Otorhinolaryngol; 2015 Oct; 272(10):3007-12. PubMed ID: 25217080
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Impact of (18)f-fluorodeoxyglucose positron emission tomography/computed tomography scan on initial evaluation of head and neck squamous cell carcinoma: our experience at a tertiary care center in India.
    Nair S; Mohan S; Nilakantan A; Gupta A; Malik A; Gupta A
    World J Nucl Med; 2015; 14(1):19-24. PubMed ID: 25709540
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The Indications for Elective Neck Dissection in T1N0M0 Oral Cavity Squamous Cell Carcinoma.
    Nguyen E; McKenzie J; Clarke R; Lou S; Singh T
    J Oral Maxillofac Surg; 2021 Aug; 79(8):1779-1793. PubMed ID: 33744243
    [TBL] [Abstract][Full Text] [Related]  

  • 75. CLIC1 plasma concentration is associated with lymph node metastases in oral squamous cell carcinoma.
    Wojtera BP; Sobecka A; Szewczyk M; Machczyński P; Suchorska WM; Golusiński W
    Adv Clin Exp Med; 2023 Mar; 32(3):341-347. PubMed ID: 36251793
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Lymph Node Ratio as a Prognostic Factor for Oral Tongue Squamous Cell Carcinoma: A Retrospective Study.
    Sundaram GA; Chokkattu JJ; Krishnan M; Kumar SP; M S; Lakshmanan S
    Cureus; 2023 Aug; 15(8):e44109. PubMed ID: 37750121
    [TBL] [Abstract][Full Text] [Related]  

  • 77. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
    Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
    Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Management of Stage III Oral Cavity Squamous Cell Carcinoma in Light of the New Staging System: a Critical Review.
    Matos LL; Guimarães YLM; Leite AK; Cernea CR
    Curr Oncol Rep; 2023 Feb; 25(2):107-113. PubMed ID: 36585962
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Expression of MiRNA-137 in oral squamous cell carcinoma and its clinical significance.
    Sun C; Li J
    J BUON; 2018; 23(1):167-172. PubMed ID: 29552778
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Development and validation of a novel TNM staging N-classification of oral cavity squamous cell carcinoma.
    de Almeida JR; Su JS; Kolarski MM; Truong T; Weinreb I; Perez-Ordonez B; Smith SM; Hosni A; Patel S; Valero C; Xu B; Ghossein R; Katabi N; Clark J; Low TH; Gupta R; Graboyes EM; Davies J; Richardson M; Pasham V; Jester R; Goldstein DP; Huang SH; Xu W; O'Sullivan B
    Cancer; 2024 Feb; 130(3):410-420. PubMed ID: 37751180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.